Na Kong

14.6k total citations · 17 hit papers
112 papers, 11.4k citations indexed

About

Na Kong is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Na Kong has authored 112 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 52 papers in Biomedical Engineering and 29 papers in Materials Chemistry. Recurrent topics in Na Kong's work include Nanoplatforms for cancer theranostics (44 papers), RNA Interference and Gene Delivery (25 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Na Kong is often cited by papers focused on Nanoplatforms for cancer theranostics (44 papers), RNA Interference and Gene Delivery (25 papers) and Advanced biosensing and bioanalysis techniques (18 papers). Na Kong collaborates with scholars based in United States, China and South Korea. Na Kong's co-authors include Wei Tao, Xiaoyuan Ji, Jiang Ouyang, Chuang LIU, Zhongmin Tang, Xinbing Sui, Xingcai Zhang, Junqing Wang, Xiangang Huang and Chan Feng and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Na Kong

107 papers receiving 11.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

2013 1.0k citations Na Kong et al. profile →
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

2013 815 citations Na Kong et al. profile →
Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications

2019 530 citations Wei Tao, Na Kong et al. Chemical Society Reviews profile →
A Novel Top‐Down Synthesis of Ultrathin 2D Boron Nanosheets for Multimodal Imaging‐Guided Cancer Therapy

2018 404 citations Xiaoyuan Ji, Na Kong et al. Advanced Materials profile →
Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics

2018 360 citations Wei Tao, Xiaoyuan Ji et al. Advanced Materials profile →
The landscape of mRNA nanomedicine

2022 339 citations Xiangang Huang, Na Kong et al. profile →
In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment

2020 308 citations Jiang Ouyang, Xiaoyuan Ji et al. profile →
Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging

2022 294 citations Jiang Ouyang, Angel Xie et al. Chemical Society Reviews profile →
mRNA-based cancer therapeutics

2023 290 citations Chuang LIU, Xiangang Huang et al. profile →
Capturing functional two-dimensional nanosheets from sandwich-structure vermiculite for cancer theranostics

2021 279 citations Xiaoyuan Ji, Chuang LIU et al. profile →
Biomaterials and nanomedicine for bone regeneration: Progress and future prospects

2021 212 citations Jun Zhou, Xingcai Zhang et al. profile →
Efferocytosis induces macrophage proliferation to help resolve tissue injury

2021 209 citations Arif Yurdagul, Chuang LIU et al. profile →
Emerging mRNA technologies: delivery strategies and biomedical applications

2022 175 citations Zhongmin Tang, Xiangang Huang et al. Chemical Society Reviews profile →
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity

2023 146 citations Yongjiang Li, Wei Chen et al. profile →
Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota

2023 135 citations Jiang Ouyang, Yongjiang Li et al. profile →
Intravesical delivery of KDM6A -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer

2022 128 citations Na Kong, Junqing Wang et al. profile →
Chemically Modified Platforms for Better RNA Therapeutics

2024 73 citations Yesi Shi, Xueyan Zhen et al. profile →

Peers

Countries citing papers authored by Na Kong

Since Specialization

Citations

This map shows the geographic impact of Na Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Kong more than expected).

Fields of papers citing papers by Na Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Kong. The network helps show where Na Kong may publish in the future.

Co-authorship network of co-authors of Na Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Na Kong. A scholar is included among the top collaborators of Na Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Kong. Na Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemically modified and inactivated bacteria enable intra-biofilm drug delivery and long-term immunity against implant infections 2026 ·Nature Biomedical Engineering ·(unknown), (unknown), (unknown), Soohwan An, Senfeng Zhao, (unknown), Na Kong, (unknown), J. Shi, (unknown), Tao Wei	0
2	Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy 2025 ·Science Advances ·(unknown), Yongjiang Li, Zhuoming Zhou, Qimanguli Saiding, Yiming Zhang, Soohwan An, Muhammad Muzamil Khan, Xiaoyuan Ji, Ruirui Qiao, Wei Tao, Na Kong, Wei Chen, Tian Xie	6
3	Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles 2025 ·Nature Nanotechnology ·Chuang LIU, Xiangang Huang, Kok‐Siong Chen, (unknown), Alexey V. Yaremenko, Xueyan Zhen, Xinru You, Filippo Rossignoli, (unknown), Seyoung Koo, Wei Chen, Na Kong, Tian Xie, Khalid Shah, Wei Tao	7
4	Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease 2025 ·Science Translational Medicine ·Xiangang Huang, Chuang LIU, (unknown), Xinru You, (unknown), Yongjiang Li, (unknown), Bin Liu, Qimanguli Saiding, Wei Chen, Yuhan Lee, Na Kong, Reza Abdi, Wei Tao	3
5	Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy 2025 ·Nature Nanotechnology ·(unknown), (unknown), Yesi Shi, Di Hu, Duyang Gao, Yan Zhang, Hao Yu, Zichao Luo, Qimanguli Saiding, Na Kong, Hongyan Qian, Yuan Liu, Hairong Zheng, Yingjia Li, Wei Tao, Zonghai Sheng	0
6	Cytokine-Related Genes and Inflammatory Profiles as Potential Biomarkers in Major Depressive Disorder 2025 ·Psychiatry Investigation ·(unknown), Na Kong, Sungwon Jung, Hee Cheol Kim, Shin Kim, Junho Kang, Hojun Lee	0
7	Lactate‐Modulating Nanozyme‐Mediated Mitochondrial Respiration Block for Tumor Immunosuppression Remodeling 2025 ·Angewandte Chemie ·Senfeng Zhao, Jianing Hou, Liu Deng, (unknown), Na Tao, Wenjie Ruan, Jia Zheng, (unknown), Qianqian Xu, Qimanguli Saiding, Na Kong, You‐Nian Liu, Wei Tao	0
8	Lactate‐Modulating Nanozyme‐Mediated Mitochondrial Respiration Block for Tumor Immunosuppression Remodeling 2025 ·Angewandte Chemie International Edition ·Senfeng Zhao, Jianing Hou, Liu Deng, (unknown), Na Tao, Wenjie Ruan, (unknown), Wei Wang, Qianqian Xu, Qimanguli Saiding, Na Kong, You‐Nian Liu, Wei Tao	10
9	Early fecal microbiota transplantation continuously improves chicken growth performance by inhibiting age-related Lactobacillus decline in jejunum 2025 ·Microbiome ·Qiyao Liu, Muhammad Faheem Akhtar, Na Kong, Rumeng Zhang, (unknown), (unknown), Danyi Yang, (unknown), Deshi Shi, Abdur Rahman Ansari, El‐Sayed M. Abdel‐Kafy, Syed Naqvi, Huazhen Liu	8
10	Therapeutic nucleic acids in regenerative medicine and tissue repair 2024 ·Nano Research ·Qimanguli Saiding, Duotian Qin, Soohwan An, Dylan Neal Patel, Muhammad Muzamil Khan, Na Kong, Wei Tao	5
11	Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment 2024 ·Advanced Materials ·Xueyan Zhen, Yongjiang Li, (unknown), Tingting Zhang, Min Li, Jinhai Huang, Na Kong, Xiaoyu Xie, Sicen Wang, Wei Tao	40
12	Titelbild: DNA‐Damage‐Response‐Targeting Mitochondria‐Activated Multifunctional Prodrug Strategy for Self‐Defensive Tumor Therapy (Angew. Chem. 16/2022) 2022 ·Angewandte Chemie ·Paramesh Jangili, Na Kong, Ji Hyeon Kim, Jun Zhou, Haijun Liu, Xingcai Zhang, Wei Tao, Jong Seung Kim	1
13	DNA‐Damage‐Response‐Targeting Mitochondria‐Activated Multifunctional Prodrug Strategy for Self‐Defensive Tumor Therapy 2022 ·Angewandte Chemie International Edition ·Paramesh Jangili, Na Kong, Ji Hyeon Kim, Jun Zhou, Haijun Liu, Xingcai Zhang, Wei Tao, (unknown), (unknown)	55
14	Stimuli-responsive prodrug-based cancer nanomedicine 2020 ·EBioMedicine ·Angel Xie, Sumaira Hanif, Jiang Ouyang, Zhongmin Tang, Na Kong, Na Yoon Kim, Baowen Qi, Dylan Neal Patel, Bingyang Shi, Wei Tao	139
15	ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and Its Guidance for Safe Biomedical Applications 2020 ·Nano Letters ·Na Kong, Xiaoyuan Ji, Junqing Wang, Xiuna Sun, Guoqiao Chen, Taojian Fan, Weiyuan Liang, Han Zhang, Anyong Xie, Omid C. Farokhzad, Wei Tao	192
16	siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice 2020 ·Science Translational Medicine ·Wei Tao, Arif Yurdagul, Na Kong, (unknown), Xiaobo Wang, Amanda C. Doran, Chan Feng, Junqing Wang, Mohammad Ariful Islam, Omid C. Farokhzad, Ira Tabas, Jinjun Shi	191
17	Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications breakdown → 2019 ·Chemical Society Reviews ·Wei Tao, Na Kong, Xiaoyuan Ji, Yupeng Zhang, Amit Sharma, Jiang Ouyang, Baowen Qi, Junqing Wang, Ni Xie, Chulhun Kang, Han Zhang, Omid C. Farokhzad, Jong Seung Kim	530
18	Drug Delivery Strategies for the Treatment of Metabolic Diseases 2019 ·Advanced Healthcare Materials ·Sanjun Shi, Na Kong, Chan Feng, Aram Shajii, (unknown), Wei Tao, Omid C. Farokhzad	47
19	Intracellular Mechanistic Understanding of 2D MoS₂ Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy 2018 ·ACS Nano ·Xianbing Zhu, Xiaoyuan Ji, Na Kong, Yunhan Chen, Morteza Mahmoudi, Xiaoding Xu, Li Ding, Wei Tao, Ting Cai, Yujing Li, Gan Tian, Austin John Barrett, Zameer Bharwani, Hongbo Chen, Omid C. Farokhzad	194
20	Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy 2018 ·ACS Nano ·Xiang Ling, Jiasheng Tu, Junqing Wang, Aram Shajii, Na Kong, Chan Feng, Ye Zhang, Mikyung Yu, Tian Xie, Zameer Bharwani, Bader M. Aljaeid, Bingyang Shi, Wei Tao, Omid C. Farokhzad	227

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact